Pfizer and Allergan announced on April 6, 2016 that their planned merger agreement has been mutually terminated. Pfizer will pay Allergan $150 million for reimbursement of expenses associated with the transaction.
The termination of the merger is a result of the US Department of Treasury aOriginal Article
